The Hydropothecary Corporation (“THCX” or the “Company”) (TSXV:THCX) is pleased to announce its processed medical marijuana products have been granted kosher certification by the Ottawa Vaad HaKashrut. It is the only kosher certification currently granted to cannabis products in Canada.
The kosher certification, includes Decarb, the ready-to-consume activated marijuana powder product line, Elixir cannabis peppermint oil and the H2 line of milled products.
“Kosher certification is important to Hydropothecary because it reflects our emphasis on rigorous testing, independent third-party oversight and our focus on easy-to-use product innovations. As the only medical marijuana company in Canada with current kosher-certified processed products, we take great pride in having the support of the Council for Kashrut,” said Hydropothecary CEO and co-founder, Sebastien St-Louis.
The announcement of the certification, by Vaad HaKashrut director, Rabbi Levy Teitlebaum, comes just in time for Rosh Hashanah, on September 20.
“Kosher certification is something that is relied upon by many people, including vegans, vegetarians and people who are careful about what they consume, as a symbol of trust. What this certification shows is the value placed on proper etiquette for kosher and for being able to care for people. That is a beautiful harmony between the Council and Hydropothecary,” Rabbi Teitlebaum said.
Obtaining kosher certification requires several components, including an audit of cleaning protocols, kosher compliance review and on-site inspections throughout the year.
“This is a rigorous, independent, third-party certification process that goes from A to Z. Hydropothecary’s products not only qualify, but certification is gladly given because it’s important for what’s needed in this new sector,” said Rabbi Teitlebaum.
About The Hydropothecary Corporation
The Hydropothecary Corporation is an authorized licensed producer and distributor of medical cannabis licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations (Canada). Hydropothecary provides sungrown and rigorously tested medical cannabis of uncompromising quality. Hydropothecary’s branding, cannabis product offering, patient service standards and product pricing are consistent with THCX’s positioning as a premium brand for a legal source for medical cannabis within this new marketplace. In addition to medical cannabis production and sales, Hydropothecary explores various research and development opportunities for cannabinoid extracts, drugs and combinatory chemistry. In addition, the company is investigating the development and patenting of novel technologies related to medical cannabis, as well as the import and export of medical cannabis.

FAQs About Kosher Certification and Medical Marijuana
Rabbi Levy Teitlebaum
Ottawa Vaad HaKashrut


What does kosher certification mean?
“Kosher certification is given to foods and consumed items that conform to kashrut or Jewish dietary law. This applies to processed foods, including plant products and animal products. Kosher ensures that what we are ingesting has been reviewed and conforms to dietary and religious needs.”
How will those taking medical marijuana know a product is kosher certified?
“Our symbol will appear on the label of every Hydropothecary product that is kosher certified. Clients can also obtain a Letter of Kosher Certification from Hydropothecary.”
Why is the advantage of kosher certification for medical marijuana products?
“As with the purchase of all consumable products, clients searching for kosher certification will know that their products adhere to the highest standards of kosher purity.”
When legalization of marijuana comes into effect in July, 2018, how will that affect kosher certification?
“Medical products required for health and wellbeing are eligible for kosher certification. With legalization of marijuana for recreational use, however, we will have to consider the ethics of using a product simply for enjoyment.”
Image Available: http://www.marketwire.com/library/MwGo/2017/9/19/11G145625/Images/Vaad_Hakashrut_logo-6eb137dc3dcba2d4903be65e1a1ca019.jpg

CONTACT INFORMATION

Source: m.marketwired.com

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less